Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Wyeth Ltd approves scheme of amalgamation with Pfizer Ltd


Sunday, 24 Nov 2013 09:55pm EST 

Wyeth Ltd:Say approved the Scheme of Amalgamation of Wyeth Ltd (Transferor Company) with Pfizer Ltd (Transferee Company).Says entire undertaking of the Transferor Company would be transferred to the Transferee Company as a going concern together with all assets and liabilities of the Transferor Company.Says Appointed Date of the Scheme would be April 01, 2013.Says consideration of the amalgamation, the Transferee Company will issue shares to the shareholders of the Transferor Company in the following swap ratio jointly recommended by the independent Valuers, Deloitte Haskins & Sells and S. R. Batliboi & Co. LLP as under.Says Seven fully paid up equity shares of Indian Rupees 10 each of Pfizer Ltd for every 10 fully paid up equity shares of Indian Rupees 10 each of Wyeth Ltd.Says Citigroup Global Markets India Private Limited has issued a fairness opinion on the swap ratio.Says Upon the Scheme coming into effect, the Transferor Company will be dissolved without being wound up. 

Company Quote

939.8
12.9 +1.39%
28 Jul 2014